Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF study of diclofenac + thiocolchicoside injection for acute low back pain
2022-000724-37Phase 3Active
- Sponsor
- Epifarma
- Start
- Jun 2022
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lumbodynia (LBP) comparing Fixed combination diclofenac + thiocolchicoside, Diclofenac active control and Placebo control (3 arms). Primary endpoint: Sum of pain intensity difference from baseline to Day 3. Started Jun 2022; status: active.
02
Drugs
diclofenacthiocolchicoside
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on 2022-000724-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000724-37.